Biomea Fusion, Inc. (BMEA) stock
BMEANasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.56−0.05 (-7.89%)
Close on Nov 12, 2026Market cap $40.79MP/E –Yield –
Biomea Fusion enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Biomea Fusion's enterprise value was $9.46M on Nov 11, 2026, against $18.22M a year earlier. Over the last 5 years it ranged from -$86.52M to $920.65M, with a median of $63.52M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $9.46M | -65.2% |
| 2025 | Dec 31, 2025 | $27.15M | -48.4% |
| 2024 | Dec 31, 2024 | $52.65M | -83.5% |
| 2023 | Dec 29, 2023 | $319.26M | +179.3% |
| 2022 | Dec 30, 2022 | $114.29M | +324.0% |
| 2021 | Dec 31, 2021 | $26.96M | – |
See a number that looks wrong?